RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect
Retinoid X receptor (<i>RXR</i>) heterodimerizes with the <i>PPAR</i> nuclear hormone receptor and regulates its downstream events. We investigated the effects of <i>RXR</i> agonists (LG100754, bexarotene, AGN194204, and LG101506) on lenalidomide’s anti-myeloma ac...
Main Authors: | Jian Wu, Xiaobei Wang, Min Zhang, Parker Mathews, Yubin Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/15/1993 |
Similar Items
-
Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma
by: Jian Wu, et al.
Published: (2022-10-01) -
CpG Methylation Altered the Stability and Structure of the i-Motifs Located in the CpG Islands
by: Daiki Oshikawa, et al.
Published: (2022-06-01) -
The genome-wide landscape of C:G > T:A polymorphism at the CpG contexts in the human population
by: Jeonghwan Youk, et al.
Published: (2020-03-01) -
DNA Methylation of Human Choline Kinase Alpha Promoter-Associated CpG Islands in MCF-7 Cells
by: Siti Aisyah Faten Mohamed Sa’dom, et al.
Published: (2021-06-01) -
CpG-Islands as Markers for Liquid Biopsies of Cancer Patients
by: Maximilian Sprang, et al.
Published: (2020-08-01)